SCHEMBL17595256

SCHEMBL17595256

CCc1cc(C(=O)OC(=O)c2c(O)c(CC)c(-c3ccc(N(CC)CC)cc3)[nH]c2=O)c(=O)[nH]c1-c1ccc(N(CC)CC)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 2/20 0.35
PDE3A Q14432 2/20 0.35
GSK3B P49841 2/20 0.34
MAPT P10636 5/20 0.33
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 4/20 0.33
NPSR1 Q6W5P4 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
LMNA P02545 2/20 0.33
XBP1 P17861 1/20 0.33
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
TSHR P16473 2/20 0.32
POLB P06746 2/20 0.32
HPGD P15428 2/20 0.32
HSD17B10 Q99714 1/20 0.32
CYP1A2 P05177 1/20 0.31
GLA P06280 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17595254 0.86 MEN1 (0.38) PDE3BPDE3AGSK3BMAPTKDM4E
SCHEMBL17594871 0.82 ALDH1A1 (0.39) PDE3BPDE3AMAPTALDH1A1LMNA
SCHEMBL17594971 0.81 LMNA (0.39) PDE3BPDE3AMAPTALDH1A1LMNA
SCHEMBL17595782 0.81 PDE3B (0.34) PDE3BPDE3AMAPTKDM4E
SCHEMBL14740984 0.80 MEN1 (0.39) GSK3BMAPTKDM4EALDH1A1NPSR1
SCHEMBL17597694 0.79 PTGER3 (0.31) PDE3BPDE3A
SCHEMBL17597217 0.78 MTNR1A (0.33) PDE3BPDE3A
SCHEMBL17595374 0.78 AURKA (0.33) PDE3BPDE3AKDM4E
SCHEMBL17594958 0.77 PDE3B (0.48) PDE3BPDE3AMAPTKDM4EALDH1A1
SCHEMBL14741112 0.77 HPGD (0.42) PDE3BPDE3AGSK3BMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016039936-A2 MONOCYCLIC SUBSTITUTED 2-PYRIDINONE ANTIBACTERIAL COMPOUNDS PTC THERAPEUTICS, INC. (US) 2016-03-17 WO claimed